Literature DB >> 8363212

Methods for voluntary weight loss and control. NIH Technology Assessment Conference Panel. Consensus Development Conference, 30 March to 1 April 1992.

.   

Abstract

One quarter to one third of Americans are overweight; as many as 40% of women and 24% of men are trying to lose weight at any given time; many have tried a variety of methods, such as diets, exercise, behavior modification, and drugs. In controlled settings, participants who remain in weight loss programs usually lose approximately 10% of their weight. However, one third to two thirds of the weight is regained within 1 year, and almost all is regained within 5 years. For many overweight persons, achieving and maintaining a healthy weight is a lifelong challenge. Successful weight loss improves several cardiovascular risk factors and diabetic control; effects on mortality are not clear. Several epidemiologic studies have found that weight loss is associated with increased mortality but the reasons for weight loss were not known. Survey data also confirm that many Americans who are not overweight, particularly young women, are trying to lose weight, which may have adverse physical and psychological consequences. Because of the importance of these issues, research on weight and on weight loss and control should assume a high priority on the nation's health agenda.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8363212

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  33 in total

Review 1.  Effective diet and exercise treatments for overweight and recommendations for intervention.

Authors:  W C Miller
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

2.  The association of race, socioeconomic status, and health insurance status with the prevalence of overweight among children and adolescents.

Authors:  Jennifer S Haas; Lisa B Lee; Celia P Kaplan; Dean Sonneborn; Kathryn A Phillips; Su-Ying Liang
Journal:  Am J Public Health       Date:  2003-12       Impact factor: 9.308

Review 3.  Dietary glycemic index and the regulation of body weight.

Authors:  David S Ludwig
Journal:  Lipids       Date:  2003-02       Impact factor: 1.880

Review 4.  Gastric pacing is not enough: additional measures for an effective obesity treatment program.

Authors:  Louis J Aronne; Jonathan A Waitman
Journal:  Obes Surg       Date:  2004-09       Impact factor: 4.129

5.  Association between short sleeping hours and overweight in adolescents: results from a US Suburban High School survey.

Authors:  Andreea Seicean; Susan Redline; Sinziana Seicean; H Lester Kirchner; Yuan Gao; Michikazu Sekine; Xiaobei Zhu; Amy Storfer-Isser
Journal:  Sleep Breath       Date:  2007-12       Impact factor: 2.816

6.  Is lost lean mass from intentional weight loss recovered during weight regain in postmenopausal women?

Authors:  Kristen M Beavers; Mary F Lyles; Cralen C Davis; Xuewen Wang; Daniel P Beavers; Barbara J Nicklas
Journal:  Am J Clin Nutr       Date:  2011-07-27       Impact factor: 7.045

7.  The cost, quality of life impact, and cost-utility of bariatric surgery in a managed care population.

Authors:  Laura N McEwen; Renuka B Coelho; Lauren M Baumann; Dori Bilik; Betsy Nota-Kirby; William H Herman
Journal:  Obes Surg       Date:  2010-07       Impact factor: 4.129

8.  Ethnic differences in the consistency and accuracy of perceived exertion.

Authors:  S Katherine Sweatt; Jane Roy; Paula Chandler-Laney; Gordon Fisher; David Brock; Gary Hunter
Journal:  Am J Hum Biol       Date:  2015-10-30       Impact factor: 1.937

9.  Acarbose treatment in obesity: a controlled study.

Authors:  F Bayraktar; F Hamulu; A G Ozgen; C Yilmaz; M Tüzün; T Kabalak
Journal:  Eat Weight Disord       Date:  1998-03       Impact factor: 4.652

Review 10.  Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

Authors:  Mousumi Bose; Blanca Oliván; Julio Teixeira; F Xavier Pi-Sunyer; Blandine Laferrère
Journal:  Obes Surg       Date:  2008-09-27       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.